Evidence map›Paper›PMID 29869116›Full record

ReviewPediatric nephrology (Berlin, Germany)2019

Treating the idiopathic nephrotic syndrome: are steroids the answer?

Georges Deschênes, Claire Dossier, Julien Hogan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Georges DeschênesDepartment of Pediatric Nephrology, APHP Robert-Debré, Sorbonne Paris Cité University, 48 Bd Sérurier, F-75019, Paris, France. georges.deschenes@aphp.fr.
Claire DossierDepartment of Pediatric Nephrology, APHP Robert-Debré, Sorbonne Paris Cité University, 48 Bd Sérurier, F-75019, Paris, France.
Julien HoganDepartment of Pediatric Nephrology, APHP Robert-Debré, Sorbonne Paris Cité University, 48 Bd Sérurier, F-75019, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of steroids in idiopathic nephrotic syndrome is the major discovery of the twentieth century in the field of pediatric nephrology. At onset of the twenty-first century, steroids remain the first line of treatment at first flare. All the protocols to treat the first flare are similar by a common sequence including a first phase of daily prednisolone/prednisone at a dose of 60 mg/m

Indexed as

ChildDose-Response Relationship, DrugDrug Administration ScheduleDrug Therapy, CombinationGlucocorticoidsHumansImmunosuppressive AgentsNephrotic SyndromePrednisolonePrednisoneRecurrenceRemission InductionSecondary PreventionTreatment OutcomeGlucocorticoidsImmunosuppressive AgentsPrednisolonePrednisoneIntravenous methylprednisolonePrednisolonePrednisoneSteroid dependencySteroid resistance

Identifiers

PMID29869116
OpenAlexW2805725790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.